ABCDEFGHIJKLMNOPQRSTUVWXYZAAABAC
1
OriginEfficacyNo. of dosesPrice per doseMain developers / sponsorsTypeStorage / transportShelf lifeNameNotes
2
Comirnaty (Pfizer / BioNTech)USA, Germany95%2 shots, 21 days apart. Booster 5 months later$19.50 for first 100 M dosesPfizer, BioNTechmRNATransport -75ºC, storage 2-8ºC up to 31 days6 months at -60°C to -90°C under cover from lightBNT162b2Suggested for persons aged 12 and older
3
Vaxzevria (AstraZeneca)UK79-80%2 shots, 4-12 weeks apart$2.15-5University of Oxford, AstraZenecaAdenovirus vector-basedTransport and storage 2-8°C6 months at 2-8°CAZD1222, VaxzevriaSuggested for persons aged 18 and older
4
Spikevax (Moderna)USA9412 shots, 28 days apart$25-37Moderna, BARDA, NIAID, CEPImRNATransport -25°C to -15°C, storage 2-8°C up to 30 days9 months at -25°C to -15°CmRNA-1273Suggested for persons aged 18 and older
5
JanssenUSA, Netherlands67-85%1 shot$10Janssen Biotech (Johnson & Johnson)Adenovirus vector-based2-8ºC6 months at 2-8ºCJNJ-78436735Suggested for persons aged 18 and older
6
CoronaVacChina, Brazil50.40-91.25%2 shots, 14-28 days apart$29.75SinovacInactivated SARS-CoV-2 virus2-8ºC24 monthsDB15806Suggested for persons aged 18 and older
7
CovaxinIndia78%2 shots, 28 days apart$2-4Bharat BiotechInactivated SARS-CoV-2 virus2-8ºC12 monthsBBV152Suggested for persons aged 18 and older
8
NovavaxUSA89%2 shots, 21 days apart$16Novavax Inc, Coalition for Epidemic Preparedness InnovationsProtein2-8ºC9 monthsNVX-CoV2373Suggested for people aged 18-59; phase III clinical trial going on. Approved to be used in the EU.
9
SinopharmChina79,00%2 shots, 21 days apart$36Beijing Institute of Biological Products; China National Pharmaceutical Group (Sinopharm)Inactivated SARS-CoV-2 virus2-8ºC2 yearsBBIBP-CorVSuggested for persons aged 18 and older
10
CovovaxUSA83.40%2 shots, 14 days apartSerum Institute of IndiaProtein2-8ºC6 monthsNVX-CoV2373/CovovaxSuggested for people aged 18 and older. Novavax version distributed in India.
11
CovishieldIndia>70%2 shots, 4 weeks apart$2.75-6.18Serum Institute of IndiaAdenovirus vector-based2-8ºC9 monthsChAdOx1 nCoV- 19Oxford-AstraZeneca version, distributed in India
12
Sputnik VRussia92%2 shots, 21 days apart< $10Gamaleya Research InstituteAdenovirus vector-basedDoses can be frozen (storage -18°C) and freeze-dried (storage 2-8°C)6 monthsGam-COVID-VacSuggested for persons aged 18 and older
13
ConvideciaChina65,70%1 shot$17-27CanSino BiologicsAdenovirus vector-based2-8ºC12 monthsAD5-nCOVSuggested for persons aged 18 and older
14
EpiVacCoronaRussia94-100%2 shots, 21-28 days apart$11Vector InstituteProtein2-8ºC2 yearsDB16439Suggested for persons aged 18 and older. Slower immunity development.
15
QazVacKazakhstan96%2 shots, 21 days apart$ 9.4Research Institute for Biological Safety ProblemsInactivated SARS-CoV-2 virus2-8ºC2 yearsDB16441Suggested for persons aged 18 and older
16
Soberana 2Cuba62%-90% after a third dose (booster)2 doses, 28 days apartFinlay Vaccine InstituteProteinFINLAY-FR-2Emergency authorized in Iran. Approved for children above 2 years old in Cuba.
17
ZifivaxChina97%3 shots, 14-21 days apartAnhui Zhifei Longcom Biopharmaceutical Co. LtdProtein2-8ºCZF2001Suggested for persons aged 18-59.
18
MedigenTaiwan2 shots, 28 days apartMedigen Vaccine Biologics CorporationProtein2-8ºCMVC-COV1901Only completed trail 1 and 2. Suggested for persons aged 20 and older
19
$ stands for USD
20
Vaccines approved for use by WHO
21
22
23
24
eucham.eu
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100